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A B S T R A C T
Herein we report the ﬁrst X-ray crystal structure of the well-known (S)-L-ala-Ni-BPB complex (1) and
compare this with the X-ray crystal structures obtained for two novel ﬂuorinated (S)-L-ala-Ni-BPB
complexes (8 and 12) that contain either an S- or R-ﬂuorine atom on the proline ring of the BPB ligand.
The preparation of complexes 8 and 12 has been enabled by the synthesis of two new ﬂuorinated BPB
ligands (7 and 11). In this work we looked to observe the structural effects that the introduction of a
single ﬂuorine atom had on the known complex 1. Arising from this, we highlight a novel ﬂuorine–nickel
interaction that on the basis of DFT calculations appears to provide additional stabilization to one of the
complexes prepared ((S)-L-ala-Ni-BPB complex 8).
 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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The introduction of a ﬂuorine atom in to a molecule can have a
remarkable effect on its physical and chemical properties, metabolic
stability and its biological activity. This has been widely exploited
within medicinal chemistry and is discussed in detail in a number of
recent review articles [1]. Fluorine substitution can also be used to
ﬁne-tune the stereo-electronic properties of a molecule and in doing
so allow conformational control [2,3]. For example b-ﬂuoro imines
have been shown by X-ray crystallographic analysis and theoretical
DFT calculations, to have a torsion angle (F) of approximately 608
about the NCCF bonds (Fig. 1), therefore, preferentially adopting a
gauche conformation [4]. This is explained by ﬁrst, the avoidance of
an electronically destabilising anti-arrangement around the NCCF
bond (Fig. 1), in which the electron-withdrawing ﬂuorine atom lies
directly opposite to the electron deﬁcient imine or ammonium group.
Second, the favoured conformation puts a hydrogen atom anti- to the
imminium or ammonium group, thus allowing a stabilising electron-
donation from sC–H to s*C–N
+ by hyperconjugation (Fig. 1). This has* Corresponding authors at: Durham University, Department of Chemistry, South
Road, Durham DH1 3LE, United Kingdom and School of Pharmacy and Biomolecular
Sciences, Byrom Street Campus, Liverpool John Moores University, Liverpool L3 3AF,
United Kingdom. Tel.: +44 191 334 2086; fax: +44 191 384 4737.
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(C.R. Coxon).
http://dx.doi.org/10.1016/j.jﬂuchem.2015.02.007
0022-1139/ 2015 The Authors. Published by Elsevier B.V. This is an open access articbeen utilised as a tool in medicinal chemistry, where introduction of
a single ﬂuorine atom with the correct stereochemistry selectively
stabilises a compound in a biologically active conformation e.g.
3-ﬂuoro-N-methyl-D-aspartic acid, whereas, the opposite enan-
tiomer stabilises an inactive conformer [5]. Furthermore, 4-ﬂuor-
oprolines have been incorporated in to collagen triple helices with
the observation that this modiﬁcation confers hyperstability
within these structures due to the above stereoelectronic effects
[6]. A similar approach using ﬂuoropyrrolidine derivatives (Fig. 1)
has also been pioneered recently by the Gilmour group as a
method to control molecular conformation in acyclic systems, and
thus, probe catalyst mechanism, reactivity and selectivity in
asymmetric organocatalysis [7].
Nickel(II) Schiff base complexes of (S)-2-[N-(N0-benzylproly-
l)amino]benzophenone (BPB) and amino acids (e.g. 1) have been
widely used as nucleophilic glycine equivalents in the asymmetric
synthesis of Ca-substituted amino acids [8]. Soloshonok et al. have
also investigated the modiﬁcation of the chelating ligand, replacing
the proline ring in 1 to prepare novel NH–Ni ligands and observing
the resulting disatereomeric ratio of the Ni-complexes and the
consequences in alkylation and Michael addition reactions [9,10].
Incorporation of ﬂuorine at the 3-position of protonated pyrrolidines
has been shown to stabilise particular conformations through
b-ﬂuoro-ammonium interactions [11]. In light of this we hypothe-
sised that incorporation of a single ﬂuorine atom on the proline ring
within the BPB ligand could offer a novel route to modulate thele under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. Fluorine-ammonium gauche effect in 5-membered nitrogen-containing
heterocycles [6].
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complex. As such, we sought to probe whether the introduction
of a ﬂuorine atom in the correct conﬁguration at the carbon beta
to the proline nitrogen atom in 1 could invoke conformational
effects, such as a ﬂuorine-ammonium ion gauche effect, leading
to complexes with an altered chelate ring conﬁguration around
the nickel atom.
Here we report the synthesis and the ﬁrst ever X-ray crystal
structure of the well-known (S)-L-Ala-Ni-BPB Schiff base complex
(1). This structure has been compared with the X-ray crystal
structures obtained for two novel ﬂuorinated (S)-L-Ala-Ni-BPB
complexes (8 and 12) that contain either an S- or R-ﬂuorine atom
on the proline ring of the BPB ligand. The preparation of complexes
8 and 12 has been enabled by the synthesis of two new ﬂuorinated
BPB ligands (7 and 11). Furthermore, we highlight a novel Ni–F
interaction and use DFT calculations to support a role for this in
stabilizing one of the nickel complexes prepared.
2. Results and discussion
We initially prepared the reported (S)-BPB ligand [12] and
corresponding (S)-L-Ala-Ni-BPB complex (1) [13] according to the
published methods and obtained crystals of 1 by slow evaporation
from acetone and methylethylketone. This was to provide a
comparison of the overall structure of 1 with the ﬂuorinated
derivatives in X-ray diffraction studies (Fig. 2). In spite of being
synthesized and used many times by researchers in the ﬁeld ofFig. 2. First reported X-ray crystal structure of (S)-L-Ala-Ni-BPB complex 1. The MEK
solvent molecule and one of the component of disordered benzyl group are omitted
for clarity. All crystal structure drawings were produced with Olex2 [15]. All
structural images produced in Hermes [16].peptide chemistry [14], the structure of complex (1) has not yet
been reported in the literature (CCDC ver. 5.35 2013). Herein, we
report the ﬁrst X-ray structure of (S)-L-Ala-Ni-complex (1) (in form
of MEK solvate).
We attempted to prepare the analogous R- and S-ﬂuorinated
nickel(II) complexes of the L-Schiff base of (S)-2-[N-(N0-benzyl-
prolyl)amino]benzophenone (BPB) and L-alanine (7 and 12)
starting from commercially available proline derivatives (Schemes
1 and 2, respectively). trans-Hydroxyproline methyl ester (trans-
HypOMe, 2) was protected as the reported [17] N-(tert-butylcar-
bamate) (3) prior to a 2-step ﬂuorination procedure employing
tetrabutylammonium diﬂuorotriphenylsilicate (TBAT) followed by
treatment with perﬂuoro-1-butanesulfonyl ﬂuoride (PBSF), with
inversion of stereochemistry at the 4-position [18]. Removal of the
Boc protecting group preceded N-benzylation using standard
conditions. Conversion of the methyl ester (6) in to the required
amide (7) was achieved directly through an oxidative process
involving potassium tert-butoxide and exposure to atmospheric
oxygen [19].
To prepare the alternative (R)-ﬂuorinated ligand (Scheme 2),
commercially sourced N-Boc-trans-4-ﬂuoro-L-proline (9) was
deprotected by treatment with triﬂuoroacetic acid and used
directly in an N-benzylation reaction without puriﬁcation (Scheme
2) [20]. On this occasion, the free acid of 10 was coupled with 2-
aminobenzophenone to afford amide 11 by initial conversion of
the acid in to a mixed anhydride intermediate [21].
With the ﬂuorinated BPB ligands (7 and 11) in hand, we
subsequently attempted to prepare the corresponding Ni-com-
plexes (Scheme 3). Following the standard protocol for complexa-
tion with Ni(II), chiral ligand 7 was treated with nickel(II) nitrate
hexahydrate and L-alanine under basic conditions with gentle
heating. This reaction was performed in parallel with the
analogous reaction to prepare the reported des-ﬂuoro complex
1. After 2 h formation of 1 was complete and afforded a deep red
solution. By comparison, more than 72 h were required for the (S)-
ﬂuorinated derivative (8) to reach completion. R-ﬂuoro-BPB ligand
11, however, formed the desired Ni(II) complex (12) rapidly, within
20 min according to TLC, however, heating was continued for 24 h
to ensure complete conversion. Crystals of complexes 8 and 12
were obtained as dark red needles by slow evaporation from
diethyl ether and the structures were determined by X-ray
analysis.
It was proposed that, with the correct (S)-stereochemistry at
the ﬂuorine position, we would be able to stabilise the existing
conformation by replacement of a hydrogen atom already
orientated in the gauche conformation with respect to the nearby
nickel-coordinating nitrogen atom (Fig. 2).
The ﬂuorinated and non-ﬂuorinated complexes were aligned
using the central nickel and its coordinated heteroatoms in
molecular viewer Hermes [16] to an RMSD of less than 0.01 A˚
(Fig. 3). The structure 8 contained two independent molecules
with virtually identical conﬁguration of the coordination polyhe-
dron of metal atom. Overlay of 1 and 8 (Fig. 4) showed that
replacement of the corresponding gauche hydrogen with ﬂuorine
does not perturb the favoured conformation with respect to
the benzyl group. We observed that the ﬂuorine atom of 8 lies in
the anticipated gauche conformation (Fig. 5), with a measured
NCCF bond torsion angle of 768 (slightly greater than 608 due to
ring strain in the pyrrolidine) that is consistent with the
corresponding non-ﬂuorinated complex (1).
Replacement of the hydrogen atom with ﬂuorine introduces
two further interesting intramolecular features in 8. First, a
putative intramolecular C–H  F bond may be observed (Fig. 5).
The existence of such interactions is controversial and many
authors have concluded that any interaction may be only providing
van der Waals stabilisation [22]. However, others have reported
Scheme 1. Reagents and conditions: (a) Boc2O, NEt3, CH2Cl2, rt, 18 h; (b) (i) TBAT, DIPEA, CH2Cl2, (ii) PBSF, rt, 72 h; (c) TFA, CH2Cl2, rt, 2 h (used in next step without
puriﬁcation); (d) benzyl bromide, K2CO3, DMF, rt, 20 h; (e) 3-aminobenzophenone,
tBuOK, THF, open to air, rt, 70 min.
Scheme 3. Reagents and conditions: (a) L-alanine, Ni(NO3)26H2O, MeOH, KOH, 60 8C, 24–72 h.
Fig. 3. X-ray crystal structure of L-Ala-Ni-(S)-FBPB complex 8.
Scheme 2. Reagents and conditions: (a) TFA, CH2Cl2, rt, 2 h (used in next step without puriﬁcation); (b) benzyl chloride, KOH,
iPrOH, 50 8C, 6 h; (c) MsCl, 2-
aminobenzophenone, Et3N, CH2Cl2.
Fig. 4. Least-squares superposition of ﬂuorinated complex 8 (grey) with non-
ﬂuorinated complex 1 (pink). (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of this article.)
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Fig. 5. Expansion of a section of complex 8 showing the measured NCCF bond
torsion angle of 768 and also displaying a putative C–H  F bond.
Fig. 7. The proline ring of complex 12 (green) is twisted, whereas the ring of
complex 8 (grey) adopts an envelope conformation. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of
this article.)
Table 1
*
N.J. Tatum et al. / Journal of Fluorine Chemistry 173 (2015) 77–8380that despite being very weak non-covalent interactions, C–H  F
interactions have been observed in organic structures, notably in
some ﬂuorobenzenes [23], and that these may be enhanced when
the proton of the C–H bond is more acidic [24]. In complex 8 the
ﬂuorine atom is found to be within hydrogen bonding distance
(2.64 A˚) of the proximal methyl hydrogens (Fig. 5). Although these
are likely to be weak interactions, this could confer additional
stability to the molecule. Second, as observed in the crystal
structure, ﬂuorine is positioned directly below the central nickel
ion at a distance of 2.97 A˚, which is smaller than the sum of their
van der Waals radii (3.10 A˚). As no alteration in the crystal
structure of 8 is observed relative to the non-ﬂuorinated
compound 1 (Fig. 4) e.g. due to repulsion between the F and Ni
atoms, this may suggest that a non-bonding interaction arises,
which may stabilise the complex.
Complex 12 was aligned to complex 1 as described above, to an
RMSD of 0.05 A˚. The greatest difference in the structures, as seen in
Fig. 6, is in the ﬂuorinated proline ring. The position of the ﬂuorine
in complex 12 abolishes the potential nickel interaction observed
in complex 8. Furthermore, the proline ring in complex 12 is
twisted, where it is in the envelope conformation in complex 8
(Fig. 7). A comparison of complex 12 with the CSD (version 5.35)
using Mogul shows the torsions within this ring to be wellFig. 6. Least squares superposition of complex 1 (pink) and complex 12 (green). (For
interpretation of the references to color in this ﬁgure legend, the reader is referred
to the web version of this article.)represented, with the nearest comparable structure only 0.898
RMSD difference over ring torsions, and with 40% of the returned
structures within 108. Finally, the NCCF torsion angle of complex
12 differs greatly from that of complex 8 (Table 1, Fig. 8), which is
an expected change resulting from introduction of equatorial and
axial substituents.
To investigate the differences between the complexes in more
detail DFT, calculations were carried out using the crystal
structures of complexes 8 and 12. By comparing the calculated
energies of the R-ﬂuorine and S-ﬂuorine complexes it would be
possible to estimate the strength of the interaction between
S-ﬂuorine and nickel. DFT calculations were performed as
implemented in the Gaussian03 package. The B3LYP functional
was used in conjunction with the 6-311 + +G** basis set. The
difference in calculated energies between the two complexes
(8 and 12) was determined to be 5.99 kJ/mol (in favour of the
S-ﬂuorine complex 8). This energy difference supports the notion
of a stabilizing non-bonding interaction between the S-ﬂuorine
and the nickel in complex 8 as observed in the X-ray structure.Fig. 8. The NCCF torsion angle of complex 12 is 152.48.
Torsion angles for FNCCH and FNCCF. For complex 1, NCCH2 angle is given as
NCCF for comparison.
Ni complex FNCCH (8) FNCCF (8)
1 73.31 161.70*
8 162.98 75.97
12 86.23 152.36
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Here we report the ﬁrst X-ray crystal structure of the known
nickel(II) Schiff base complex (1). This structure has been
compared with the X-ray crystal structures obtained for two
novel ﬂuorinated nickel(II) Schiff base complexes that contain
either an S- and R-ﬂuorine atom beta to the proline nitrogen on the
BPB ligands (8 and 12, respectively). We discovered that the
introduction of an S-ﬂuorine atom (complex 8) has no signiﬁcant
effect upon the overall structural geometry of the complex.
However, whilst we accept that these may be artifacts of the
structures being solved in the crystal form, we speculate that
inclusion of a S-ﬂuorine atom may enhance the stability of complex
8 through a combination of the formation of a C–H  F bond and a
novel Ni  F non-bonding interaction. DFT calculations support
this hypothesis, with a clear difference in the calculated energies
of 5.99 kJ/mol between the S-ﬂuorinated complex 8 and the R-
ﬂuorinated complex 12 (no Ni  F interaction observed in the X-ray
structure). Introduction of the R-ﬂuorine atom substituent
(complex 12) also afforded no signiﬁcant overall changes to the
structure although as expected some minor conformational
changes in the proline ring of complex 12 were observed. Further
investigations to probe any differences between complex 1 and the
ﬂuorinated complexes 8 and 12, with regard to reactivity and
stability, are currently underway.
4. Experimental
4.1. Materials
L-4-trans-Hydroxyproline methyl ester hydrochloride (2) (Nova-
biochem) and N-Boc-cis-4-ﬂuoro-L-proline methyl ester (9) (Sigma
Aldrich) were purchased from commercial suppliers and used
directly as indicated in the appropriate experimental procedures.
All other chemicals were purchased from Sigma Aldrich. Complex 1
[10] and intermediates 3 [12] and 4 [13] were prepared according
to literature procedures and the obtained analytical data was in
accordance with the published characterizations. The preparation
of N-benzyl-(S)-4-ﬂuoro-L-proline methyl ester (6) followed a
previously undescribed route (details below) but analysis indicated
that this was identical to the reported substance [19].
4.2. Characterization
NMR spectra were collected using Bruker Avance 400 MHz or
Varian VNMRS 700 MHz spectrometers. Multiplicities are reported
as: s = singlet, d = doublet, m = multiplet, t = triplet or combina-
tions thereof e.g. dd = doublet of doublets. Chemical shifts are
reported in ppm and are referenced to residual solvent peaks;
CHCl3 (
1H 7.26 ppm, 13C 77.2 ppm), H2O (
1H 4.79 ppm). J couplings
are measured in Hertz (Hz). Reactions were monitored by TLC
using Merck precoated silica gel plates. Column chromatography
was performed using silica gel with the solvent system indicated.
All reported yields refer to the isolated yield and the product purity
was estimated to be >95% by 1H NMR. IR spectra were recorded on
a Perkin Elmer Spectrum RX1 ﬁtted with an ATR attachment. IR
absorptions reported are in cm1. Mass spectra were collected on a
Waters TQD mass spectrometer and accurate mass spectra were
collected on a Waters LCT Premier XE mass spectrometer. Optical
rotations were measured using a Jasco P-1020 polarimeter
with samples in the solvents, temperatures and concentrations
as indicated.
4.2.1. N-Benzyl-(S)-4-ﬂuoro-L-proline methyl ester (6) [19]
A solution of 4 (0.50 g, 2.00 mmol) in CH2Cl2 (25 mL) and
triﬂuoroacetic acid (2.5 mL) was stirred at room temperature for2 h. Upon completion of the reaction, volatiles were removed
under reduced pressure, affording a colourless solid (0.29 g,
quant.). Triﬂuoroacetate salt 5 was used directly in the subsequent
step without further puriﬁcation. Potassium carbonate (1.47 g,
10.6 mmol) was added to a rapidly stirred suspension of 5 (0.55 g,
2.12 mmol) in anhydrous DMF (50 mL) and gradually reached
homogeneity after 1 h at room temperature. Benzyl bromide was
added in one portion and the reaction mixture was stirred for a
further 48 h at room temperature until TLC indicated the complete
consumption of starting materials. The crude mixture was poured
over crushed ice and stirred until thawing was complete and the
emulsion was extracted with Et2O (100 mL), which was then
washed with brine (sat.) (3  30 mL). Puriﬁcation by column
chromatography (silica; EtOAc—hexane 0% to 50%) afforded the
desired product (0.39 g, 75%). All analyses were consistent with
the reported preparation [25].
Pale yellow oil, 1H NMR (400 MHz, CDCl3): d 7.35–7.22 (m, 5H,
Ph), 5.08 (dm, J = 54.7 Hz, 1H, CHF), 4.02 (d, J = 13.1 Hz, 1H, benzyl
CH), 3.69 (s, 3H, OMe), 3.58 (d, J = 13.1 Hz, 1H, benzyl CH), 3.33–
3.20 (m, 2H, CH2), 2.63–2.42 (m, 2H, CH2), 2.27 (m, 1H, CH);
13C
NMR (101 MHz, CDCl3): d 172.2, 136.4, 128.1, 127.3, 126.3, 91.0 (d,
JC–F = 173.2 Hz), 62.7, 58.2 (d, JC–F = 22.1 Hz), 56.8, 51.0, 36.2 (d, JC–
F = 22.1 Hz);
19F NMR (376 MHz, CDCl3): d 168.99 (m, 1F); LCMS
(ESI+) 238.09 [M + H]+.
4.2.2. (S)-2-[N-(N0-benzyl-(S)-4-ﬂuoro-L-
prolyl)amino]benzophenone (7)
The methyl ester 6 (0.26 g, 1.1 mmol) was added to a solution of
tBuOK (0.25 g, 2.19 mmol) in moist THF (15 mL), which was pre-
stirred open to the air for 1 min. Addition of 2-aminobenzophe-
none (0.22 g, 1.1 mmol). After stirring at room temperature for 1 h
TLC indicated that the reaction was incomplete. Additional tBuOK
(123 mg, 1.1 mmol) was added and again stirred for 1 h. The crude
mixture was concentrated in vacuo and partitioned between
CH2Cl2 (20 mL) and water (20 mL). The organic extract was dried
(MgSO4) and concentrated to an oil. The title compound was
isolated after column chromatography (silica; EtOAc—hexane 0%
to 30%) (97 mg, 22%) as a pale yellow oil.
½ / 23D 41.1 (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3): d 11.61
(s, 1H, NH), 8.55 (d, J = 8.3 Hz, 1H, Ar), 7.83–7.75 (m, 2H, Ar), 7.62–
7.56 (m, 1H, Ar), 7.56–7.45 (m, 4H, Ar), 7.45–7.38 (m, 2H, Ar), 7.22–
7.15 (m, 3H, Ar), 7.09 (t, J = 7.6 Hz, 1H, Ar), 5.10 (dt, J = 52.9, 4.1 Hz,
1H, CHF), 4.00 (d, J = 13.0 Hz, 1H, benzyl CH), 3.63 (d, J = 13.0 Hz,
1H, benzyl CH), 3.55–3.39 (m, 2H, CH), 2.70–2.43 (m, 2H, CH2), 2.31
(m, 1H, CFCH), 1.26 (s, 1H, CH); 13C NMR (101 MHz, CDCl3): d 199.1,
172.2, 139.7, 139.0, 137.6, 133.5, 132.7, 128.3, 127.5, 127.3, 126.2,
125.2, 121.7, 120.9, 92.2 (d, JC–F = 179.5 Hz), 62.4, 58.4 (d, JC–
F = 22.0 Hz), 57.0, 51.1, 36.6 (d, JC–F = 22.1 Hz);
19F NMR (376 MHz,
CDCl3): d 172.11 (m, 1F); IR (neat) y 3320, 2945, 1675, 1655,
1287, 1115, 703 cm1; LCMS (ESI+) m/z = 403.19 [M + H]+. HRMS
(ESI) calcd for C25H24FN2O2 [M + H]
+: m/z = 403.1812, found
403.1822.
4.2.3. L-Ala-Ni-(S)-ﬂuoro-BPB complex (8)
To a solution of 7 (27 mg, 0.08 mmol) and Ni(NO3)26H2O
(44 mg, 0.15 mmol) in anhydrous methanol (2 mL) was added a
solution of KOH (34 mg, 0.60 mmol) and L-alanine (34 mg,
0.38 mmol) in methanol (1 mL). This mixture was heated at
60 8C with stirring for 72 h—TLC indicated the reaction was
complete and the deep red solution concentrated in vacuo before
partitioning between water (30 mL) and CHCl3 (20 mL). Trituration
of the concentrated organic extract under Et2O afforded a dark red
solid that was isolated by ﬁltration under suction and washed with
more Et2O. Puriﬁcation of the crude material by preparative TLC
(silica; acetone—CHCl3 20%) afforded a red/orange solid (22 mg,
55%).
N.J. Tatum et al. / Journal of Fluorine Chemistry 173 (2015) 77–8382mp 288–290 8C (dec.); ½ / 27D þ 255 (c = 2.0, CHCl3); 1H NMR
(700 MHz, CDCl3): d 8.09 (d, J = 7.9 Hz, 3H, Ar), 7.54–7.47 (m, 2H,
Ar), 7.47–7.42 (m, 1H, Ar), 7.38 (t, J = 7.7 Hz, 2H, Ar), 7.25–7.21 (m,
2H, Ar), 7.14 (ddd, J = 8.7, 6.9, 1.8 Hz, 1H, Ar), 6.97 (dm, J = 7.7 Hz,
1H, Ar), 6.67 (m, 1H, Ar), 6.62 (dd, J = 7.7, 1.8 Hz, 1H, Ar), 5.49 (dm,
J = 52.7 Hz, 1H, CHF), 4.59 (d, J = 12.7 Hz, 1H, benzyl CH), 3.99 (m,
1H, CH), 3.90 (m, 1H, CH), 3.65 (dd, J = 11.6, 4.7 Hz, 1H, CH), 3.58 (d,
J = 12.7 Hz, 1H, benzyl CH), 2.91 (m, 1H, CH), 2.76 (m, 1H, CH), 2.25
(ddd, J = 36.4, 11.6, 3.5 Hz, 1H, CH), 1.60 (m, 3H, CH3);
13C NMR
(101 MHz, CDCl3): d 179.9, 170.1, 141.9, 133.4, 133.1, 132.6, 131.9,
131.7, 129.6, 129.2, 129.0, 128.8, 127.5, 127.2, 126.7, 123.8, 120.8,
91.4 (d, J = 179.0 Hz), 68.6, 66.9, 62.9, 61.5 (d, J = 20.4 Hz), 38.4 (d,
J = 22.4 Hz), 20.3; 19F NMR (376 MHz, CDCl3): d 167.18 (m, 1F);
LCMS (ESI+) m/z = 530.12 [M + H]+; HRMS (ESI) calcd for
C28H27FN3O3Ni [M + H]
+: m/z = 530.1382, found 530.1390.
4.2.4. N-Benzyl-(R)-4-ﬂuoro-L-proline hydrochloride salt (10)
A solution of N-Boc-(R)-4-ﬂuoro-L-proline (0.5 g, 2. 18 mmol) in
CH2Cl2 (25 mL) and triﬂuoroacetic acid (2.5 mL) was stirred at
room temperature for 2 h. Upon completion of the reaction, volatiles
were removed under reduced pressure, affording a colourless solid
(0.52 g, quant.). The triﬂuoroacetate salt was used directly in the
subsequent step without further puriﬁcation. A solution of the salt
in isopropanol (5 mL) was added to a fully dissolved solution of
potassium hydroxide (0.61 g, 10.9 mmol) in isopropanol (25 mL),
followed by dropwise addition of benzyl chloride (350 mL, 3.1 mmol)
with stirring at 50 8C for 6 h. The pH was adjusted to around 5 by
addition of concentrated hydrochloric acid and extracted with
CHCl3 (20 mL). Solids were removed by ﬁltration and washed with
CHCl3 (2  10 mL). The organic extracts were combined and
concentrated in vacuo to a pale oil, which was triturated under
cold acetone (20 mL) and the resulting analytically pure white solid
was isolated by ﬁltration and washed with more cold acetone
(10 mL). Additional product was isolated from the acetone washings
and was combined with the initial crop (0.37 g, 66%).
mp 213–215 8C; ½ / 27D þ 18:9 (c = 0.95, H2O); 1H NMR (400 MHz,
D2O): d 7.49–7.34 (m, 5H, Ph), 5.41 (dt, J = 51.7, 3.9 Hz, 1H, CHF),
4.54–4.38 (m, 3H, CH and benzyl CH2), 3.98–3.63 (m, 2H, CH2), 2.78
(m, 1H, CH), 2.25 (dm, J = 39.3 Hz, 1H, CHF); 13C NMR (101 MHz,
D2O): d 170.7, 130.7, 130.3, 129.3, 91.8 (d, JC–F = 171.7 Hz), 66.5, 60.6,
59.8 (d, JC–F = 21.7 Hz), 36.3 (d, JC–F = 21.7 Hz);
19F NMR (376 MHz,
D2O): d 173.53 (m, 1F); IR (neat) y 3037, 2944, 1644, 1159
712 cm1; LCMS (ESI+) 224.28 [M + H]+.
4.2.5. (S)-2-[N-(N0-benzyl-(R)-4-ﬂuoro-L-
prolyl)amino]benzophenone (11)
Methanesulfonyl chloride (105 mL, 1.36 mmol) was added
slowly to a solution containing N-methylimidazole (216 mL,
2.72 mmol) and proline acid 10 (0.28 g, 1.24 mmol) in CH2Cl2,
cooled to 0 8C. After stirring for 10 min, the ﬂask was removed from
the ice bath, and 2-aminobenzophenone (0.22 g, 1.12 mmol) was
added and the reaction mixture was stirred at 50 8C for 20 h. The
reaction was quenched by addition of sat. NH4Cl aq. (10 mL), the
organic phase was extracted CH2Cl2 (2  20 mL) and volatiles
were removed under reduced pressure. The crude mixture was
puriﬁed by column chromatography (silica; 1:9 ethyl acetate-
hexane) and isolated as a pale brown oil (0.38 g, 76%).
½ / 24D 14.1 (c = 1, CHCl3); 1H NMR (400 MHz, CDCl3): d 11.59 (s,
1H, NH), 8.59 (dd, J = 8.4, 1.1 Hz, 1H, Ar), 7.81–7.74 (m, 2H, Ar),
7.65–7.59 (m, 1H, Ar), 7.58–7.47 (m, 4H, Ar), 7.46–7.41 (m, 2H, Ar),
7.19–7.13 (m, 3H, Ar), 7.10 (ddd, J = 8.2, 7.3, 1.1 Hz, 1H, Ar), 5.35
(dm, J = 52.0, Hz, 1H, CHF), 4.03 (d, J = 13.0 Hz, 1H, benzyl CH),
3.78–3.65 (m, 2H, CH and benzyl CH), 3.48 (ddd, J = 34.8, 13.1,
4.2 Hz, 1H, CH), 2.90 (ddt, J = 28.5, 13.0, 1.8 Hz, 1H, CH), 2.72–2.55
(m, 1H, CH), 2.22–2.01 (m, 1H, CH); 13C NMR (101 MHz, CDCl3): d
198.3, 172.9, 139.2, 138.5, 137.9, 133.6, 132.8, 132.6, 130.1, 129.0,128.4, 128.3, 127.3, 124.9, 122.4, 121.6, 93.6 (d, JC–F = 180.1 Hz),
67.8, 60.6, 59.3 (d, JC–F = 22.0 Hz), 38.7 (d, JC–F = 22.1 Hz);
19F NMR
(376 MHz, CDCl3): d 171.49 (m, 1F); IR (neat) y 3296, 1703, 1521,
1264, 1169, 733 cm1; LCMS (ESI+) m/z = 402.98 [M + H]+; HRMS
(ESI) calcd for C25H24FN2O2 [M + H]
+: m/z = 403.1810, found
403.1822.
4.2.6. L-Ala-Ni-(S)-ﬂuoro-BPB complex (12)
To a solution of 11 (0.11 g, 0.27 mmol) and Ni(NO3)26H2O
(0.16 g, 0.55 mmol) in anhydrous methanol (3 mL) was added a
solution of KOH (0.12 mg, 2.20 mmol) and L-alanine (0.12 g,
1.37 mmol) in methanol (2 mL). This mixture was heated at
60 8C with stirring for 24 h—TLC indicated the reaction was
complete and the deep red solution concentrated in vacuo before
partitioning between water (30 mL) and CHCl3 (20 mL). Trituration
of the concentrated organic extract under Et2O afforded a dark red
solid that was isolated by ﬁltration under suction and washed with
more Et2O. The washings were combined and evaporated and
triturated again to obtain further material, which was analytically
pure without further puriﬁcation (0.10 mg, 71%).mp 296–298 8C;
½ / 24D þ 241 (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3): d 8.28–
8.22 (m, 2H, Ar), 8.03 (dd, J = 8.7, 1.1 Hz, 1H, Ar), 7.55–7.47 (m, 2H,
Ar), 7.47–7.41 (m, 1H, Ar), 7.38 (t, J = 7.7 Hz, 2H, Ar), 7.30–7.17 (m,
2H, Ar), 7.12 (ddd, J = 8.7, 6.8, 1.9 Hz, 1H, Ar), 6.96–6.90 (m, 1H, Ar),
6.70–6.59 (m, 2H, Ar), 5.68 (dm, J = 55.1 Hz, 1H, CHF), 4.42 (d,
J = 12.4 Hz, 1H, benzyl CH), 4.25 (ddd, J = 32.8, 14.4, 4.3 Hz, 1H, CH),
3.95–3.81 (m, 2H, CH), 3.65 (d, J = 12.4 Hz, 1H, benzyl CH), 3.32
(dddd, J = 35.7, 15.1, 10.9, 4.5 Hz, 1H, CH), 2.94 (m, 2H, CH), 1.54 (d,
J = 7.0 Hz, 3H, CH3);
13C NMR (101 MHz, CDCl3): d 180.4, 178.9,
170.8, 142.0, 133.5, 133.4, 133.3, 132.4, 131.8, 129.9, 129.4, 129.1,
129.0, 127.6, 127.3, 126.4, 123.8, 121.1, 91.4 (d, JC–F = 178.6 Hz),
70.1, 66.5, 65.5, 64.0 (d, JC–F = 21.7 Hz), 39.4 (d, JC–F = 21.6 Hz), 21.8;
19F NMR (376 MHz, CDCl3) d 173.86 (m, 1F); LCMS (ESI+) m/
z = 530.06 [M + H]+; HRMS (ESI) calcd for C28H27FN3O3Ni [M + H]
+:
m/z = 530.1385, found 530.1390.
5. X-ray crystal structure determination and structural
analysis
The X-ray single crystal data have been collected on a Bruker
SMART CCD 6000 (compound 8, sealed ﬁne-focus tube, graphite
monochromator, lMo Ka, l = 0.71073 A˚) and D8Venture (com-
pounds 1 and 12, ImS-microsource, focusing mirrors, Photon
100 CMOS detector, lCu Ka, l = 1.54178 A˚ and lMo Ka,
l = 0.71073 A˚, respectively) diffractometers equipped with the
Cryostream (Oxford Cryosystems) open-ﬂow nitrogen cryostats at
the temperature 120.0(2) K. All structures were solved by direct
method and reﬁned by full-matrix least squares on F2 for all data
using Olex2 [15] and SHELXTL [26] software. All non-disordered
non-hydrogen atoms were reﬁned anisotropically, hydrogen atoms
in structure 8 were reﬁned isotropically. The atoms of disordered
groups in structure 1 were reﬁned with ﬁxed SOF values in isotropic
approximation. The hydrogen atoms in these groups and in the
structures 1 and 12 were placed in the calculated positions and
reﬁned in riding mode. Crystallographic data for the structures
has been deposited with the Cambridge Crystallographic Data
Centre as supplementary publication CCDC 1052145–1052147.
Crystal data for 1: C28H27N3NiO3  C4H8O (M = 584.34), ortho-
rhombic, space group P212121, a = 9.0963(2), b = 12.1090(3),
c = 26.0025(6) A˚, V = 2864.10(12) A˚3, Z = 4, m(Cu Ka) = 1.312 mm1,
Dcalc = 1.355 g/mm
3, 21,312 reﬂections measured, 5425 unique
(Rint = 0.0260) were used in all calculations. The ﬁnal R1 was 0.0470
(5218 > 2s(I)) and wR2 was 0.1297 (all data), S = 1.051.
Crystal data for 8: C28H26N3O3FNi (M = 530.23): orthorhombic,
space group P212121, a = 9.4749(5), b = 11.3449(7), c = 44.685(3) A˚,
V = 4803.2(5) A˚3, Z = 8, m(Mo Ka) = 0.852 mm1, Dcalc = 1.466 g/mm
3,
N.J. Tatum et al. / Journal of Fluorine Chemistry 173 (2015) 77–83 8378,710 reﬂections measured, 12,765 unique (Rint = 0.0738) were used
in all calculations. The ﬁnal R1 was 0.0364 (10,213 > 2s(I)) and wR2
was 0.0766 (all data), S = 0.978.
Crystal data for 12: C28H26N3O3FNi (M = 530.23): orthorhombic,
space group P212121, a = 9.6711(8), b = 10.0617(8), c = 24.6671(19) A˚,
V = 2400.3(3) A˚3, Z = 4, m(Mo Ka) = 0.853 mm1, Dcalc = 1.467 g/cm
3,
33,745 reﬂections measured, 6370 unique (Rint = 0.0834) which were
used in all calculations. The ﬁnal R1was 0.0584 (5748 > 2s(I)) and wR2
was 0.1369 (all data), S = 1.077.
These data can be viewed free of charge via http://www.ccdc.
cam.ac.uk/cont/retrieving.html or from the CCDC, 12 Union Road,
Cambridge CB2 1EZ, UK; fax: +44 1223 336033 E-mail: depos-
it@ccdc.cam.ac.uk.
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